Actively Recruiting
Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
Led by Wen-Hsin Huang · Updated on 2024-10-31
548
Participants Needed
1
Research Sites
45 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
"The colorectal cancer mortality rate in Taiwan ranks third among all cancers, so it is crucial to prevent colorectal cancer through regular colonoscopy screenings and remove polyps with higher cancer risk. However, during colonoscopy, doctors tend to miss about 22% to 28% of polyps, and 20% to 24% of these missed polyps may turn into cancerous adenomas. Introducing an Artificial Intelligence (AI) assisted system can improve the overall quality of colonoscopy. This study aims to evaluate the effectiveness of the ASUS AI-assisted system (EndoAim) in diagnosing polyps during colonoscopy. It includes comparing the outcomes of colonoscopy with and without the use of EndoAim and assessing the impact of EndoAim on diagnostic effectiveness across different subgroups. Each participant will be randomly assigned to undergo a colonoscopy with or without the assistance of EndoAim. The performance of the AI-assisted system in colonoscopy will be comprehensively evaluated using indicators such as APC(Adenoma Per Colonoscopy), ADR(Adenoma Detection Rate), PDR(Polyp Detection Rate), and Positive Predictive Value (PPV).. A subgroup analysis will also be conducted based on several important factors. Polyps will be biopsied and sent for pathological examination, with the pathology report serving as the final diagnosis for subsequent analysis."
CONDITIONS
Official Title
Prospective Study of EndoAim: ASUS AI Solution for Colorectal Polyp Diagnosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20 or older
- Undergoing colonoscopy using the Olympus series endoscopes
- Following a low-residue diet and undergoing bowel preparation
You will not qualify if you...
- Poor bowel cleansing evaluated as Poor or Inadequate according to the Aronchick scale
- Incomplete colonoscopy (not reaching the cecum)
- Use of anticoagulant medications or abnormal coagulation function within the last 5 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China Medical University Hospital
Taichung, North Dist., Taiwan, 404332
Actively Recruiting
Research Team
H
Hsing-Hung Cheng, MD
CONTACT
W
Wen-Hsin Huang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here